Mendaera
United Kingdom · Biotechnology, Health Care · 25 employees
Mendaera is developing technology that will enable all healthcare providers to do more for their patients. Our platform combines real-time imaging, robotics, and artificial intelligence to make precise and consistent intervention more accessible. Our aim is to eliminate barriers in the patient journey, accelerate recovery, delight customers, and reduce cost of care.
Funding history
- Series series b — $73.0M — Sep 2024
- Funding Round — $24.0M — Aug 2023
Recent signals
- Jan 09, 2025: Mendaera Appoints Eric Davidson as Chief Commercial Officer (CCO)
- Oct 08, 2024: EchoNous Partners with Mendaera to Revolutionize Image-Guided Intervention
- Sep 26, 2024: Raised $73.0M in Series series b
- Aug 18, 2023: Raised $24.0M
See plans & pricing → Track Mendaera’s funding, hiring, and signals — with verified contacts — on Fundz.